Drug pricing

US policy study warns Swiss pharma industry could lose billions

US customs policy: Study warns of billions in losses for the pharmaceutical industry

This content was published on Aug 27, 2026 A industry-backed study estimates potential losses for the Swiss pharma industry from US policies could be in the billions.

New treatments

Swiss non-profit drugmakers team up as funding shrinks

This content was published on Aug 25, 2026 Waning commitments to global health causes and big pharma’s financial imperatives are threatening the development of innovative drugs to help patients left on the sidelines of medicine.

Drug pricing

Swiss pharma group warns access to new medicine is worsening

This content was published on Aug 13, 2026 Swiss pharma companies warn current pricing rules delay access to new medicines.

Health systems

Federal audit finds Swiss hospitals fail to pass on discounts to patients

This content was published on Aug 13, 2026 A federal audit has found that doctors’ practices, hospitals and pharmacies don't always pass on discounts on medicines to patients.

A patient at the Swiss Paraplegic Centre walking down the corridor

Health systems

Swiss healthcare costs rise faster than patients can keep up

This content was published on Jun 25, 2026 As Switzerland’s mandatory health insurance turns 30, an affordability crisis is forcing the country to take some difficult decisions to secure its future.

Schwan identified protectionism by the United ‌States and China as the firm's biggest geopolitical worry.

Healthcare innovation

Roche chair compares US tariff policy to ‘blackmail’

This content was published on Jun 5, 2026 Roche chair slams US tariffs as “blackmail" and warns rising US-China protectionism is top geopolitical risk.

Sandoz on the offensive against Chinese antibiotics on sale

Drug pricing

Swiss drugmaker complains of Chinese antibiotics dumping

This content was published on May 28, 2026 Sandoz steps up criticism of imports of low-priced antibiotics from China.

Drug pricing

Truth or tale: can pharma companies set prices for new drugs as high as they want?

This content was published on May 6, 2026 Debates over drug pricing have prompted Swissinfo readers to ask whether pharma companies can set prices for new drugs as high as they want.

Drug pricing

The drug-pricing problem no one wants to talk about

This content was published on May 4, 2026 Tackling the misuse of patents by some big pharma companies could go a long way to bringing down drug prices.

Full transparency from the FOPH on Covid-19 vaccines

Drug pricing

Swiss court forces Covid vaccine procurement transparency

This content was published on Apr 16, 2026 Court forces Switzerland to release unredacted Covid vaccine contracts from the pandemic.

Drug pricing

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Drug pricing

More

US policy study warns Swiss pharma industry could lose billions

More

Swiss non-profit drugmakers team up as funding shrinks

More

Swiss pharma group warns access to new medicine is worsening

More

Federal audit finds Swiss hospitals fail to pass on discounts to patients

More

Swiss healthcare costs rise faster than patients can keep up

More

Roche chair compares US tariff policy to ‘blackmail’

More

Swiss drugmaker complains of Chinese antibiotics dumping

More

Truth or tale: can pharma companies set prices for new drugs as high as they want?

More

The drug-pricing problem no one wants to talk about

More

Swiss court forces Covid vaccine procurement transparency

Popular Stories

Most Discussed